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bstract
Atherosclerosis, the main cause of cardiovascular disease (CD), is a chronic inflammatory condition associated with an overpro-
uction of oxidant species, namely peroxynitrite, which is a powerful oxidant that reacts directly with all biomolecules. Glutathione
s an efficient scavenger of peroxynitrite, so, modulation of glutathione synthesis may provide a strategy to selectively protect cells
rom this oxidant. Here, we investigated the ability of resveratrol, a component of red wine, to prevent peroxynitrite-mediated
ndothelial cells toxicity and the underlying mechanism. Bovine aortic endothelial cells (BAEC) in primary cultures were treated
ith authentic peroxynitrite and the cell viability and intracellular glutathione contents were assessed. Our results demonstrate that
long pre-incubation (14 h) of BAEC with resveratrol (1–50M) leads to the endothelial cells rescue from injury triggered byuthentic peroxynitrite by a mechanism of up-regulation of the intracellular GSH content, for the highest resveratrol concentration
ested. Considering the importance of GSH in regulation of cell life, this capacity of resveratrol provides a new mechanism for its
ardioprotective effects and may contribute to the development of novel therapeutic strategies.
2006 Elsevier Ireland Ltd. All rights reserved.
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. Introduction
Atherosclerosis is a chronic inflammatory condition
haracterized by lipid accumulation, smooth muscle pro-
iferation and monocyte recruitment to the endothelium
ollowing endothelial cell dysfunction associated with
Abbreviations: BSO, L-buthionine SR-sulfoximine; ONOO−, per-
xynitrite; BAEC, bovine aortic endothelial cells; LDL, low density
ipoproteins; GSH, glutathione; GSSG, glutathione disulfide; Res,
esveratrol
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oxidative stress [1]. This oxidative stress is the result of
an increase of reactive species that are able to mediate
LDL oxidation and several deleterious cellular effects
that may culminate in cell death. Virtually, all vascu-
lar cells produce reactive species, via specific cellular
enzymes, as NADPH and xanthine oxidases, the main
sources of superoxide anion (O2•−) production, and
NO synthase which produces nitric oxide (NO•) [2].
Although NO• is an antiatherogenic molecule due to
its beneficial effects on vascular wall [2], it can react
rapidly with O •−, in a diffusion-controlled reaction,2
leading to the formation of peroxynitrite (ONOO−), a
powerful oxidant and nitrating species [3]. Peroxyni-
trite may oxidize and covalently modify a wide range
of biomolecules, including DNA, proteins and lipids,
ed.
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as well as various low-molecular-weight biomolecules
[4–6]. These modifications can affect important cellu-
lar functions in such a way that cell homeostasis may
be compromised and subsequently apoptosis or necro-
sis may occur. The involvement of peroxynitrite in
atherosclerosis has been suggested either by its ability to
oxidize LDL, or by the extensive nitration of protein tyro-
sine observed in human atherosclerotic lesions [7–10].
Then, it is crucial to counteract peroxynitrite damaging
effects and one of the possible strategies is to scavenge
it.
Glutathione (GSH) is the principal non-protein thiol
involved in the antioxidant defence and is the major
contributor to the cellular redox state [11]. GSH is
ubiquitously present in all cell types at millimolar con-
centrations and is distributed among nucleus, endo-
plasmic reticulum and mitochondria. Despite the fact
that the rate constant for the reaction between GSH
and peroxynitrite is not too high, the high intracellu-
lar GSH concentration turns it into the most likely and
important endogenous low-molecular-weight molecule
for scavenging peroxynitrite [12]. Additionally, GSH
is implicated in peroxynitrite-detoxification through its
enzymatic system, being glutathione peroxidase able to
reduce peroxynitrite to nitrite at the expenses of GSH.
Actually, Ma et al. [13] have shown that GSH depletion
in hypercholesterolemic rabbits exacerbated the dam-
aging effects of peroxynitrite on vasculature functions,
strengthening the crucial role of GSH in peroxynitrite
detoxication.
On the other hand, resveratrol (3,4′,5-trihydroxy-
stilbene), a natural phytoalexin found in wine, specially
red wine, has been suggested to be one of the active ingre-
dients responsible for cardiovascular benefits of moder-
ate wine consumption, due to its numerous biological
activities such as inhibition of LDL oxidation, inhibi-
tion of smooth muscle cells proliferation and inhibition
of platelet aggregation [14–17]. However, the underlying
mechanisms responsible for its cardioprotective effects
are still largely unknown. Recently, Cao and Li group
has demonstrated that resveratrol induces an increase in
GSH intracellular content in cardiomyocytes and smooth
muscle cells [18,19]. Thus, following our previous work
showing that resveratrol protects efficiently LDL against
peroxynitrite-induced oxidation [15], and knowing that
resveratrol increases GSH and that this molecule is rel-
evant to peroxynitrite-detoxification, we hypothesized
that resveratrol could prevent cell death by peroxyni-
trite by increasing GSH. Accordingly, in this study,
using primary cultures of bovine aortic endothelial cells
(BAEC) as a model system, we determined the resver-
atrol concentration-dependent induction of intracellularteractions 164 (2006) 157–166
GSH and the protection afforded by resveratrol against
peroxynitrite-elicited endothelial cell death.
Our data indicate that resveratrol is able to decrease
the programmed cell death in BAEC stimulated by bolus
addition of authentic peroxynitrite, not by a direct reac-
tion with this oxidant but rather by increasing GSH
intracellular content.
2. Materials and methods
2.1. Materials
General laboratory chemicals and some specific ones,
namely, collagenase, gelatine, streptomycin/penicillin,
MTT, BSO, Hoechst 33258, ortho-phthaldeyde and GSH
were obtained from Sigma Chemicals (St. Louis, MO).
For cell culture, Dulbecco’s modified Eagle’s medium
(DMEM), trypsin 0.25%, fungizone, fetal bovine serum
(FBS) and phosphate-buffered saline (PBS) pH 7.4, were
purchased from Gibco-Invitrogen. Resveratrol was from
Extrasynthe`se (Genay, France).
2.2. Primary cultures of bovine aortic endothelial
cells
Bovine aortic endothelial cells (BAEC) were obtained
from thoracic aorta by treatment with collagenase
(2 mg/ml). Cells were cultivated on gelatine-coated tis-
sue culture plastic in DMEM supplemented with 10%
fetal bovine serum, 100 U/ml penicillin, 100g/ml
streptomycin and 50g/ml fungizone at 37 ◦C, in a
humidified atmosphere of 5% CO2. Endothelial cells
were identified by their cobblestone morphology and
uptake of fluorescently labelled acetylated LDL. Cells
were subcultured at confluences and used between the
fourth and the seventh passage. Prior to the experiments,
cells at 80% of confluence were starved in serum-free
medium for 24 h.
2.3. Peroxynitrite synthesis
Peroxynitrite was synthesized by using a quenched
flow reactor, as previously described [20]. Briefly, an
aqueous solution of 0.6 M NaNO2 was mixed rapidly
with an equal volume of 0.7 M H2O2 containing 0.6 M
HCl and immediately quenched with the same volume of
1.5 M NaOH. The solution was then frozen at −20 ◦C for
approximately 24 h. At this temperature, peroxynitrite
concentrates into a dark yellow top layer (freeze fraction-
ation), which was removed and passed through a short
column of MnO2 for residual H2O2 remotion accord-
ing to Uppu et al. [21]. Then it was stored at −80 ◦C
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nder N2 atmosphere. Before use, ONOO− was always
uantified from the absorbance at 302 nm in 1N NaOH
ε= 1670 M−1cm−1).
.4. Peroxynitrite-induced oxidative stress
In the experiments with ONOO−, cells were washed
reviously once and equilibrated with PBS (phosphate
uffered saline with calcium and magnesium) pH 7.4 for
min. Subsequently, ONOO−, diluted in 10 mM NaOH
o the required concentration, was delivered as a single
olus, at the respective concentrations, against one side
f the dish while rapidly swirling the medium to assure
ptimal exposure of the cells to ONOO− before decom-
osition. Cells were exposed to ONOO− for 10 min,
fter which they were washed and replaced in culture
edium for 6 h. No pH shift was observed during treat-
ent with ONOO−. PBS rather than DMEM was used
or peroxynitrite-treatment to avoid interfering reactions
f ONOO− with the media constituents. The same vol-
mes of either 10 mM NaOH (vehicle control) or decom-
osed ONOO− (ONOO− was decomposed in PBS or
0 mM NaOH overnight) were used as controls. When
equired, cells were pre-incubated with resveratrol, BSO
buthionine sulfoximine) or both for 14 h. At the end of
he indicated time, the incubation medium was gently
emoved and the cells were incubated with peroxynitrite
s described above. In these conditions, resveratrol or
SO were not present in the incubation medium through-
ut the experiment with peroxynitrite.
.5. Cell viability assay
Cells (0.5 × 106 cells/well) seeded in 6-well plates
ere incubated with various concentrations of BSO for
4 h. Cell viability was then assessed by the MTT test
ccording to Denizot and Lang [22]. Briefly, after the
ncubation period, the medium was removed, the cells
ere washed with PBS and further, 1 ml of PBS con-
aining 100l of MTT (1 g/l) was added to each well
or 1 h at 37 ◦C. Formazan crystals were dissolved in
MSO and the absorbance was read at 530 nm. Results
ere expressed as a percentage of control cells.
.6. LDH measurement
The cell lysis (necrosis) was evaluated by the lactate
ehydrogenase (LDH) release. Lactate dehydrogenase
eleased into the cultured medium was spectropho-
ometrically evaluated in an auto analyzer Synchron
X (Beckman Coulter) following the manufacturer’s
nstructions. Results were expressed as percentage ofteractions 164 (2006) 157–166 159
total LDH release, obtained by division of the LDH
activity in the supernatant by the LDH activity in
supernatant plus the LDH activity in cell lysate.
2.7. Nuclear morphology
Cells were fixed with freshly prepared 4% (w/v)
paraformaldehyde in phosphate buffered saline (PBS,
pH 7.4) for 15 min at room temperature and subsequently
stained with Hoechst dye 33258 (5g/ml) for 15 min,
washed with PBS and mounted by using PBS/glycerol
(3:1, v/v). Then, cells were examined by fluorescence
microscopy, with a Nikon fluorescence microscope.
Stained nuclei were scored according to the conden-
sation and staining characteristics of chromatin. Apop-
totic nuclei were identified by condensed chromatin and
nuclear fragmentation and were counted in at least five
random microscopic fields (400×) per sample. Only
cells that remained attached to the plates were observed.
Mean values were expressed as the percentage of apop-
totic nuclei.
2.8. Measurement of cellular reduced and oxidized
glutathione
Intracellular levels of GSH and GSSG were deter-
mined by a fluorimetric assay as previously described
[23]. In brief, cells were scrapped with 0.6 M perchloric
acid and recovered into 100 mM sodium phosphate
buffer containing 5 mM EDTA, pH 8.0 at 4 ◦C. Samples
were centrifuged at 14,000 rpm at 4 ◦C for 10 min.
A volume of 100l of supernatant was incubated
with 100l of ortho-phthaldehyde (0.1% w/v in
methanol) and 1.8 ml of 100 mM Na2HPO4 for 15 min
at room temperature. For the GSSG determination the
supernatant was previously treated during 30 min with
N-ethylmaleimide (NEM) and then incubated with
ortho-phthaldehyde in 100 mM NaOH. Fluorescence
intensity was then read in a Perkin-Elmer LS 50B
spectrometer at an emission wavelength of 420 nm with
an excitation wavelength of 350 nm (slits width 5 nm).
Cellular GSH and GSSG contents were calculated using
concurrently run standard curves and expressed as nmol
of GSH or GSSG per milligram of cellular protein.
Cellular protein content was quantified by the Bio-Rad
protein assay dye, using bovine serum albumin as the
standard.2.9. Statistical analysis
All data were expressed as mean ± S.E.M. of at least
three independent assays, each one in duplicate. Differ-
gical In160 P.M. Brito et al. / Chemico-Biolo
ences between groups were analysed by one-way analy-
sis of variance (ANOVA) or Student’s test. A value of p
lower than 0.05 was considered statistically significant.
3. Results
3.1. Peroxynitrite-induced morphological apoptotic
changes in BAEC
Peroxynitrite-induced cell death has been described
in several cell types, including BAEC [24]. However,
these reports differ not only in the cell type studied
but also in the peroxynitrite source and peroxynitrite-
treatment and subsequently in the cell death type
induced-apoptosis versus necrosis. To understand the
nature of the cell death triggered by authentic peroxyni-
trite, BAEC toxic effects were evaluated 6 h after treat-
ment of cells with peroxynitrite concentrations ranging
from 100 to 600M. The plasma membrane integrity,
a feature of necrosis, was assessed by measuring LDH
release to the medium. A slight increase in LDH release
was observed with increasing concentrations of per-
oxynitrite (Fig. 1A). However, this increase was not
statistically different even for the highest peroxynitrite
concentration tested. On the other hand, a concentration-
dependent increase in apoptotic cell number, quantified
after nuclear staining with Hoechst 33258, could be
Fig. 1. Peroxynitrite induces morphological apoptotic changes in BAEC. Con
serum, were treated with several concentrations of authentic peroxynitrite (0–6
in 1 ml/well of PBS for 10 min. Subsequently, PBS was removed and repla
leakage (A) was evaluated in culture medium, as described in Section 2. Resu
apoptotic changes (B) were assessed by nuclear morphology observation und
being considered apoptotic cells all those with condensed or fragmented nucle
are mean ± S.E.M. of four experiments, each one assayed in duplicate. **p <teractions 164 (2006) 157–166
observed (Fig. 1B). In fact, cells treated with the high-
est peroxynitrite concentrations used (500 and 600M)
exhibited significant nuclear condensation or fragmen-
tation (about 20 and 30%, respectively), whereas these
apoptosis hallmarks were not evident in untreated cells
(less than 2% of untreated cells exhibited nuclear con-
densation or fragmentation).
3.2. Resveratrol prevented peroxynitrite-mediated
apoptotic changes
In order to determine the preventive effects of
resveratrol against peroxynitrite-mediated cell death,
BAEC were pre-incubated with several concentrations
of resveratrol (1–50M) for 14 h, followed by treat-
ment with 500M ONOO− as described in Section
2. Resveratrol was not present in the medium during
or after peroxynitrite-treatment. Although the oxidative
stress induced by 500M ONOO− caused apoptotic
cell death of about 25% of BAEC after 6 h of treatment
with peroxynitrite, pre-treating cells with resveratrol for
14 h markedly reverted the programmed cell death in
a dose-dependent manner (Fig. 2). Ten micromolar of
resveratrol inhibited apoptosis by 50%, whereas 1M
resveratrol had no significant effect. Nearly complete
protection was observed in cells pre-incubated with 25
and 50M resveratrol.
fluent bovine aortic endothelial cells, maintained in a medium free of
00M). After washing of cells with PBS, treatments were performed
ced by fresh serum-free media and incubated at 37 ◦C for 6 h. LDH
lts were expressed as the percentage of total cell lysis. Morphological
er a fluorescent microscope after nuclei staining with Hoechst 33258,
i. Results were expressed as the % of the total cell population. Values
0.01 vs. control.
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Fig. 2. Resveratrol prevents peroxynitrite-mediated apoptotic
changes. Confluent bovine aortic endothelial cells maintained in a
medium free of serum were pre-incubated with several concentrations
of resveratrol (Res) (1–50M) for 14 h. Subsequently, cells were
washed with PBS and treated with 500M peroxynitrite as described
in legend of Fig. 1. Morphological apoptotic changes were then
assessed after nuclei staining with Hoechst 33258. Control refers
to the experiment in similar conditions without peroxynitrite and
resveratrol. Values are mean ± S.E.M. of four experiments, each
one assayed in duplicate. ==p < 0.01 vs. control; **p < 0.01 vs.
peroxynitrite-treated cells.
Fig. 3. Resveratrol prevents peroxynitrite-mediated glutathione depletion: (A
bars) and GSSG (white bars) were quantified at different times (0–180 min) af
after pre-incubation with 10 and 50M resveratrol and GSH was quantified
Section 2. Control refers to incubated BAEC alone. Values are mean ± S.E.M
control, *p < 0.05 vs. peroxynitrite-treated cell.teractions 164 (2006) 157–166 161
3.3. Resveratrol prevented GSH depletion induced
by peroxynitrite
To evaluate the mechanism of resveratrol protec-
tion on peroxynitrite-induced apoptosis of BAEC, we
examined its influence on glutathione, the most abun-
dant cellular antioxidant and a preferential target for
peroxynitrite-mediated oxidation. In agreement with
this statement, a significant decrease in intracellular
GSH content was detected at the end of peroxynitrite-
treatment (time 0). However, after this initial decrease,
the cellular GSH content reached the control levels
15 min after the cell treatment with peroxynitrite, which
were maintained for at least 180 min. In contrast, the
intracellular GSSG content increased slightly at the end
of peroxynitrite-treatment, but after 15 min it decreased
to the control level and it was maintained during all
the time of the experience, as shown in Fig. 3A. Pre-
incubation of BAEC with 50M resveratrol prevented
GSH depletion mediated by peroxynitrite in about 50%,
but no significant effect could be observed with 10M
resveratrol (Fig. 3B). To clarify how resveratrol pre-
vented peroxynitrite-mediated GSH depletion as well
as the differences between resveratrol concentrations
tested, we analyzed the resveratrol impact, per se, on
intracellular GSH and GSSG contents in the absence of
peroxynitrite. As evidenced in Fig. 4, a slight increase in
the constitutive intracellular GSH content was observed
in cells treated with 10M resveratrol. However, pre-
incubation of cells with 50M resveratrol-induced an
) BAEC were incubated with 500M peroxynitrite and GSH (grey
ter cells treatment. (B) Cells were treated with 500M peroxynitrite,
immediately at the end of the treatment (time 0 min) as described in
. of five experiments each one assayed in duplicate. ***p < 0.001 vs.
162 P.M. Brito et al. / Chemico-Biological In
Fig. 4. Resveratrol per se increases GSH content in BAEC. Resveratrol
(10 and 50M) was added to cells and incubated for 14 h. Subse-
quently, GSH (grey bars) and GSSG (white bars) were quantified as
described in Section 2. Values are mean ± S.E.M. of six experiments
each one assayed in duplicate. **p < 0.01 vs. control (experiment with-
out resveratrol).
increase in GSH content of about two-fold. Of notice,
the GSSG content was constant, either in the absence
(control) or presence of resveratrol.
3.4. BSO enhanced peroxynitrite-induced cell deathTo establish a link between the intracellular GSH
content increase and the cytoprotective effect of 50M
resveratrol, cells were treated with BSO. BSO is a potent
and selective inhibitor of γ-glutamylcysteinyl ligase, the
Fig. 5. BSO effects on cellular GSH content and cell viability. Cells were in
Then, GSH levels (A) or cell viability (B) were determined as described in
assayed in duplicate. *p < 0.05 vs. control.teractions 164 (2006) 157–166
rate limiting enzyme in de novo synthesis of GSH [25].
Thus, cells were firstly incubated with several concentra-
tions of BSO for 14 h and the effect on the intracellular
GSH content was evaluated. Whereas concentrations of
50, 100 and 200M of BSO did not significantly affect
the intracellular GSH content, 500M BSO caused a
decrease in about 45% and no further decrease was
observed for higher concentrations, as shown in Fig. 5A.
Moreover, none of the concentrations tested affected cell
viability (Fig. 5B), as evaluated by the MTT test. Accord-
ingly, 500M BSO was selected for further experiments.
Then, the effect of BSO-induced cellular GSH deple-
tion on cell death mediated by peroxynitrite was studied
(Fig. 6). A pre-incubation of BAEC with 500M BSO
for 14 h followed by a treatment with several concentra-
tions of peroxynitrite (50–500M) resulted in a two- to
three-fold increase in the apoptotic cell number, denoting
a dramatic exacerbation of cytotoxicity induced by per-
oxynitrite. As the number of apoptotic cells observed for
250M ONOO− plus BSO was similar to that observed
for 500M peroxynitrite alone (Figs. 1B and 2), we used
250M peroxynitrite to look up to the protective effects
of resveratrol on peroxynitrite-induced cell death in the
presence of BSO.
3.5. Co-treatment with BSO blocked
resveratrol-mediated cytoprotectionTo clarify the mechanism underlying the protection
afforded by resveratrol against peroxynitrite toxicity,
cells were pre-incubated with resveratrol in the pres-
ence of BSO followed by peroxynitrite-treatment. Co-
cubated with various concentrations of BSO (0–1000M) for 14 h.
Section 2. Values are mean ± S.E.M. of three experiments each one
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Fig. 6. BSO enhances peroxynitrite-mediated cell death. Cells pre-
incubated in the absence or presence of 500M BSO for 14 h were
treated with several concentrations of peroxynitrite (50–500M) as
described previously. Six hours after peroxynitrite-treatment, the apop-
totic cell number was assessed as described in Section 2. Results
are expressed as the % of the total cell population. Values are
mean ± S.E.M. of four experiments, each one assayed in duplicate.
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Fig. 7. BSO reverts the resveratrol-induced increase in cellular GSH
content. Cells were incubated with either 500M BSO, or 50M
resveratrol or both, for 14 h. GSH cellular levels were then quantified
as described in Section 2. Values are mean ± S.E.M. of three experi-
ments, each one assayed in duplicate. **p < 0.01 vs. control (experiment
without BSO and Res), ***p < 0.001 vs. control and ===p < 0.001 vs.
resveratrol.
Fig. 8. BSO inhibits resveratrol protective effects in peroxynitrite-
mediated cell death. BAEC alone (control) or pre-treated with 500M
BSO or 500M BSO plus 50M resveratrol, were incubated withp < 0.001 vs. control (experiment without ONOO and BSO),
p < 0.05 vs. control, ===p < 0.001 vs. the same concentration of
NOO− and ==p < 0.01 vs. the same concentration of ONOO−,
p < 0.05 vs. the same concentration of ONOO−.
ncubation of cells with resveratrol and BSO completely
bolished the resveratrol-induced increase in cellular
SH content (Fig. 7). On the other hand, approximately
5% of cells underwent apoptosis by pre-incubation
ith BSO followed by 250M peroxynitrite-treatment
Fig. 8). The co-incubation of 50M resveratrol with
SO slightly protected cells against apoptosis mediated
y ONOO−, as the number of apoptotic cells decreased
nly about 6% relative to the control, i. e., the assay with-
ut resveratrol (Fig. 8). Therefore the protection afforded
y resveratrol in endothelial cells against ONOO− was
ignificantly reduced in the presence of BSO when com-
ared with that observed in similar conditions without
SO (a decrease in about 21% relative to the assay with
NOO− alone) (Fig. 2).
. DiscussionA large body of evidences point to a prominent role
f resveratrol as an anti-atherosclerotic agent [see 26
or review and references in there]. This has been, par-
250M peroxynitrite for 10 min in PBS. The number of apoptotic
cells was assessed 6 h after this treatment. Results are expressed as the
percentage of the total cell population. Values are mean ± S.E.M. of
five experiments, each one assayed in duplicate. **p < 0.01 vs. control,
*p < 0.05 vs. control and =p < 0.05 vs. ONOO−.
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tially, supported by its ability to reduce oxidative stress
occurring in the arterial wall during the atherosclerotic
process. Resveratrol has been shown to reduce LDL oxi-
dation, a significant contributor to oxidative stress in the
vasculature and a critical event in atherogenesis, medi-
ated by different initiators, such as copper, peroxyni-
trite and ferrylmyoglobin [14,15]. Furthermore, resver-
atrol can affect several enzymatic systems leading to a
decrease in the formation of intracellular oxidant reactive
species in vascular cells, as well as, to an improvement
in the cellular redox state, via antioxidants induction,
increasing cell resistance to injury elicited by reactive
species [26 and references therein]. Actually, in vitro
studies, carried out by Cao and Li [18] in cardiomy-
ocytes and by Li et al. [19] in aortic smooth muscle
cells, demonstrate that resveratrol induces an increase
in either cellular GSH content, or in different enzyme
activities, namely glutathione-dependent enzymes, cata-
lase and superoxide dismutase. In addition, preliminary
in vivo studies from the same authors point out that
resveratrol is also capable of inducing the expression
of cardiac antioxidants and phase two enzymes in mice
after oral administration [27]. On the other hand, it is
well known that glutathione and related enzymes are
important cellular tools to detoxify oxidants, namely per-
oxynitrite. Actually, several recent studies report that
GSH depletion enhances peroxynitrite-induced stress,
characterized for example by an inflammatory response
and vascular injury [28]. Previously, we have reported
that resveratrol prevents efficiently the LDL apopro-
tein from oxidation mediated by peroxynitrite, being
resveratrol rather oxidized than nitrated by such species
[15]. Taking into account all this background, we inves-
tigated whether resveratrol could protect cells from
peroxynitrite-mediated injury and looked up to a pos-
sible underlying mechanism via intracellular GSH, as to
our knowledge no report exists in this issue.
Our results show that addition of authentic perox-
ynitrite to BAEC elicited a non-necrotic programmed
cell death, at the highest concentrations tested (500 and
600M), triggering condensation and fragmentation of
nucleus without LDH leakage to the medium (Fig. 1A
and B). Such effects are in agreement with those reported
by Foresti et al. [24], suggesting an apoptotic pathway for
peroxynitrite-induced cell death. However, results from
Szabo´ et al. [29], with a similar range of peroxynitrite
concentrations, are controversial suggesting a different
pattern of cell death since they observed activation of the
nuclear enzyme poly-ADP-ribose polymerase, an event
related to cell necrosis rather than apoptosis [30]. These
different effects may be the result of different experimen-
tal conditions, such as the exposure time of the cells toteractions 164 (2006) 157–166
the oxidant and the medium used, cell culture medium
or buffer. As referred above, and on basis of prelimi-
nary work (results not shown), phosphate buffer was used
to avoid the secondary effects of the reaction products
between peroxynitrite and DMEM.
Pre-incubation of cells with 10, 25 and 50M
resveratrol, for 14 h, significantly protected them from
peroxynitrite-mediated injury (Fig. 2), an effect not
observed at the lowest concentration tested (1M). Nev-
ertheless, only at the highest concentration (50M)
resveratrol prevented significantly the GSH depletion
induced by peroxynitrite (Fig. 3B) which is in agree-
ment with the observation that only at this concentration
a significant increase in the intracellular GSH pool was
stimulated by resveratrol per se (Fig. 4). It should be
highlighted that resveratrol effects can be ascribed to
its direct action on cell, since it was removed from the
medium before the oxidant cell treatment. On the other
hand, the decrease in GSH after peroxynitrite-treatment
was not followed by the corresponding increase in oxi-
dized glutathione (GSSG), as shown in Fig. 3A, sug-
gesting that this decrease was rather due to a removal of
GSH out of the cell or to a S-nitrosation of glutathione
by peroxynitrite [11,31].
As aforementioned, GSH is a key player in
peroxynitrite-detoxification, either directly as a scav-
enger or indirectly as a cofactor of the enzymes serving
the glutathione-mediated detoxification process. To pro-
vide a direct evidence for the involvement of resveratrol-
induced GSH increase in its cytoprotective effect against
peroxynitrite, a series of experiments were designed in
the presence of an inhibitor of GSH synthesis, such as
BSO. BSO inhibits specifically and irreversibly the γ-
glutamylcysteine synthetase (γ-GCS), thereby limiting
the intracellular GSH [11,25]. Actually, de novo synthe-
sis of GSH is mediated by two ATP-dependent enzymes:
the γ-GCS and the glutathione synthetase, being the for-
mer the rate limiting enzyme, subject to a feedback inhi-
bition by GSH. Another relevant factor in de novo GSH
synthesis is the availability of cysteine [25]. This could
explain the rapid recovery (15 min) of intracellular GSH
content after peroxynitrite-treatment (Fig. 3A) given that
at this time, the cells had been already in the presence
of cell culture medium containing available cysteine for
cellular uptake and subsequently for GSH synthesis. The
co-incubation of cells with peroxynitrite and a non-toxic
concentration of BSO enhanced significantly cell death
caused by peroxynitrite (Fig. 6), supporting the impor-
tant role of GSH in the protection against oxidant species.
Moreover, BSO was able to abolish the intracellular
GSH increase due to the pre-incubation of cells with
50M resveratrol (Fig. 7), pointing out that resveratrol-
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ediated GSH increase occurred through induction of
-GCS.
To clarify the resveratrol cytoprotective strategy
gainst peroxynitrite-mediated cell death we compared
uch protection in the absence and presence of BSO
Fig. 8). Of note, on basis of the results from Fig. 6, in
he experiment with BSO we used only 250M perox-
nitrite. Interestingly, cells pre-incubated for 14 h with
0M resveratrol were strongly protected against injury
licited by peroxynitrite alone (Fig. 2), but in the pres-
nce of BSO, no significant protection could be observed
Fig. 8). These results strongly suggest that resveratrol,
t a concentration of 50M prevents cells from perox-
nitrite deleterious effects by increasing the intracellular
SH pool.
Regarding the molecular mechanisms by which an
ncrease in intracellular GSH protects cells from death
nduced by peroxynitrite several pathways are possi-
le. On the one hand, the two-fold increase in GSH
nduced by resveratrol, shown in this work, could
lightly increase the cellular capacity to reduce per-
xynitrite through a non-catalyzed reaction. On the
ther hand, the increase in cellular GSH concentration
ncreases the glutathione peroxidase activity (GPx), a
iologically efficient peroxynitrite-detoxification path-
ay in vivo. In fact, kinetic studies show that the
Px-catalyzed reaction of peroxynitrite outcompetes the
on-catalyzed reduction of peroxynitrite with GSH by
factor of 3 [32,33]. Also, glutathione S-transferases
ould be implicated in the resveratrol protective mech-
nism. Some of these enzymes, namely the microsomal
nes, exhibit a glutathione peroxidase activity, reduc-
ng lipid hydroperoxides generated in cellular mem-
ranes by oxidants. Thus, the increase in the cellular
evels of GSH, may increase the peroxidase activity of
ST decreasing lipid peroxidation products and conse-
uently modulating signalling for apoptosis. Worthy of
ote, the microsomal GST is activated by peroxynitrite
34,35].
At lower concentrations, a different protective path-
ay must be implicated. Actually, 10M resvera-
rol reduced efficiently peroxynitrite-induced cell death
Fig. 2) but such protection was not associated neither
ith a significant inhibition of GSH depletion in the
resence of the oxidant (Fig. 3B) nor with a significant
ncrease in the GSH intracellular content (Fig. 4). There-
ore, resveratrol, at this concentration and in our model
ystem, has a protective role in the biochemical path-
ays implicated in the peroxynitrite-induced cell death,
ut a large number of potential mechanisms may be con-
idered as peroxynitrite may mediate cell injury and cell
eath by multiple pathways [36].
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In conclusion, our study demonstrates for the first
time that a long pre-incubation of BAEC with resveratrol
is able to rescue endothelial cells from injury triggered
by authentic peroxynitrite in a concentration-dependent
manner. Furthermore, this cytoprotective effect seems
to be afforded by an increase in the intracellular GSH
pool for the highest concentration of resveratrol tested.
Thus, our data provides a strong contribution to the view
that resveratrol cardioprotective effects go far beyond
its classical antioxidant activity, being able to modulate
redox cellular state by increasing the GSH intracellular
levels.
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